| Primary |
| Colorectal Cancer Metastatic |
27.6% |
| Nausea |
13.8% |
| Back Pain |
10.3% |
| Blood Cholesterol Increased |
10.3% |
| Gastrooesophageal Reflux Disease |
10.3% |
| Hypertension |
10.3% |
| Type 2 Diabetes Mellitus |
10.3% |
| Insomnia |
3.4% |
| Premedication |
3.4% |
|
| Extrapyramidal Disorder |
40.0% |
| Anaphylactic Reaction |
20.0% |
| Paranoia |
20.0% |
| Partial Seizures |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
47.6% |
| Nausea |
11.3% |
| Drug Use For Unknown Indication |
6.5% |
| Pain |
4.8% |
| Vomiting |
4.8% |
| Sedation |
4.0% |
| Sleep Disorder |
3.2% |
| Ill-defined Disorder |
2.4% |
| Cerebrovascular Disorder |
1.6% |
| Hyperemesis Gravidarum |
1.6% |
| Insomnia |
1.6% |
| Metabolic Disorder |
1.6% |
| Oesophageal Disorder |
1.6% |
| Premedication |
1.6% |
| Pyrexia |
1.6% |
| Acute Myeloid Leukaemia |
0.8% |
| Arrhythmia |
0.8% |
| Cardiovascular Event Prophylaxis |
0.8% |
| Cerebrovascular Accident |
0.8% |
| Cerebrovascular Accident Prophylaxis |
0.8% |
|
| Renal Failure Acute |
22.2% |
| Pancreatic Carcinoma |
11.1% |
| Choreoathetosis |
5.6% |
| Maternal Exposure During Pregnancy |
5.6% |
| Nausea |
5.6% |
| Serotonin Syndrome |
5.6% |
| Tachycardia |
5.6% |
| Weight Decreased |
5.6% |
| Anaphylactic Reaction |
2.8% |
| Dystonia |
2.8% |
| Extrapyramidal Disorder |
2.8% |
| Hypophagia |
2.8% |
| Lichenoid Keratosis |
2.8% |
| Lip Swelling |
2.8% |
| Maternal Distress During Labour |
2.8% |
| Oculogyric Crisis |
2.8% |
| Oedema Mouth |
2.8% |
| Oedema Mucosal |
2.8% |
| Poor Quality Sleep |
2.8% |
| Skin Burning Sensation |
2.8% |
|
| Concomitant |
| Nausea |
19.6% |
| Vomiting |
15.0% |
| Drug Use For Unknown Indication |
12.7% |
| Back Pain |
12.1% |
| Product Used For Unknown Indication |
10.0% |
| Pain |
4.0% |
| Prophylaxis |
3.4% |
| Diffuse Large B-cell Lymphoma |
3.3% |
| Prostate Cancer Metastatic |
3.1% |
| Constipation |
2.7% |
| Non-small Cell Lung Cancer |
2.6% |
| Prophylaxis Of Nausea And Vomiting |
1.7% |
| Hypertension |
1.4% |
| Hormone Therapy |
1.4% |
| Multiple Myeloma |
1.4% |
| Type 2 Diabetes Mellitus |
1.3% |
| Gastric Cancer |
1.2% |
| Breast Cancer Metastatic |
1.1% |
| Hepatic Neoplasm Malignant |
1.1% |
| Prostate Cancer |
1.0% |
|
| Vomiting |
24.9% |
| Nausea |
13.0% |
| Pyrexia |
5.4% |
| Dehydration |
4.7% |
| Renal Failure |
4.7% |
| Thrombocytopenia |
4.7% |
| Urinary Tract Infection |
4.3% |
| Death |
3.6% |
| Pneumonia |
3.6% |
| Confusional State |
3.2% |
| Glioblastoma Multiforme |
2.9% |
| Hypoxia |
2.9% |
| Neutropenia |
2.9% |
| Premature Baby |
2.9% |
| Renal Impairment |
2.9% |
| Syncope |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
| Febrile Neutropenia |
2.5% |
| Pain |
2.5% |
| Pulmonary Embolism |
2.5% |
|
